Skip to main content
Premium Trial:

Request an Annual Quote

GATC Biotech's NGSelect

GATC Biotech has launched NGSelect, a modular system for next-generation sequencing projects. The company offers pre-defined modules that encompass pre-sequencing, library preparation, sequencing, and bioinformatics. Customers can scale sequencing output starting with as little as 5 million reads. The module workflows are fully automated to provide speed and cost efficiencies, according to the company.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.